NCT00937079View on ClinicalTrials.gov

Whole Body 111In-exendin-4 Imaging Study in Insulinoma Patients

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions
HyperinsulinismHypoglycemiaInsulinoma
Interventions
OTHER

111In-exendin-4 imaging

90-100 megabecquerel (MBq) (30 microgram or less) 111In-exendin-4 IV once

Trial Locations (1)

CH-4031

University Hospital Basel, Institute of Nuclear Medicine, Basel

All Listed Sponsors
lead

University Hospital, Basel, Switzerland

OTHER

NCT00937079 - Whole Body 111In-exendin-4 Imaging Study in Insulinoma Patients | Biotech Hunter | Biotech Hunter